These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31444234)

  • 1. Azathioprine and the neurologist.
    McWilliam M; Khan U
    Pract Neurol; 2020 Feb; 20(1):69-74. PubMed ID: 31444234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic considerations in patients with refractory neurosarcoidosis.
    Agbogu BN; Stern BJ; Sewell C; Yang G
    Arch Neurol; 1995 Sep; 52(9):875-9. PubMed ID: 7661724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for prescribing azathioprine in dermatology.
    Anstey AV; Wakelin S; Reynolds NJ;
    Br J Dermatol; 2004 Dec; 151(6):1123-32. PubMed ID: 15606506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].
    Schwab M; Herrlinger K; Schaeffeler E; Stange EF
    Dtsch Med Wochenschr; 2003 Feb; 128(8):378-85. PubMed ID: 12594624
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-tumor necrosis factor agents reduce corticosteroid use compared with azathioprine in patients with Crohn's disease.
    Kane SV; Jaganathan S; Bedenbaugh AV; Palmer L; Schwartz DA
    Curr Med Res Opin; 2014 Sep; 30(9):1821-6. PubMed ID: 24884302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of thiopurine methyltransferase activity in the safety and efficacy of azathioprine in the treatment of pemphigus vulgaris.
    Firooz A; Ghandi N; Hallaji Z; Chams-Davatchi C; Valikhani M; Karbakhsh Davari M
    Arch Dermatol; 2008 Sep; 144(9):1143-7. PubMed ID: 18794458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azathioprine in dermatology: a survey of current practice in the U.K.
    Tan BB; Lear JT; Gawkrodger DJ; English JS
    Br J Dermatol; 1997 Mar; 136(3):351-5. PubMed ID: 9115914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.
    Murphy LA; Atherton D
    Br J Dermatol; 2002 Aug; 147(2):308-15. PubMed ID: 12174104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of TPMT in heart transplant recipients under immunosuppressive therapy with azathioprine.
    Gummert JF; Schütz E; Oellerich M; Mohr FW; Dalichau H
    Artif Organs; 1995 Sep; 19(9):918-20. PubMed ID: 8687298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Pavlidis P; Stamoulos P; Abdulrehman A; Kerr P; Bull C; Duley J; Ansari A
    Inflamm Bowel Dis; 2016 Jul; 22(7):1639-46. PubMed ID: 27271488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunodepressive agents in neurology].
    Sabouraud O
    Rev Prat; 1986 Jan; 36(5):229-36. PubMed ID: 2870559
    [No Abstract]   [Full Text] [Related]  

  • 14. Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine.
    de Boer NK; van Nieuwkerk CM; Aparicio Pages MN; de Boer SY; Derijks LJ; Mulder CJ
    Eur J Gastroenterol Hepatol; 2005 Apr; 17(4):457-61. PubMed ID: 15756101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease.
    Kim SJ; Yu HG
    Ocul Immunol Inflamm; 2007; 15(5):381-7. PubMed ID: 17972222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine: a guide for the management of dermatology patients.
    Wise M; Callen JP
    Dermatol Ther; 2007; 20(4):206-15. PubMed ID: 17970886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.
    Ansari A; Hassan C; Duley J; Marinaki A; Shobowale-Bakre EM; Seed P; Meenan J; Yim A; Sanderson J
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1743-50. PubMed ID: 12269967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiopurine methyltransferase screening before azathioprine therapy.
    Gauba V; Saldanha M; Vize C; Saleh GM
    Br J Ophthalmol; 2006 Jul; 90(7):923-4. PubMed ID: 16782959
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-dose azathioprine effectively suppresses clinical and immunological manifestations of generalized myasthenia.
    Finsterer J; Frank M; Krexner E
    South Med J; 2010 Feb; 103(2):182-4. PubMed ID: 20065912
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.